Literature DB >> 9579818

Heart involvement and HIV infection in African patients: determinants of survival.

B Longo-Mbenza1, K V Seghers, M Phuati, F N Bikangi, K Mubagwa.   

Abstract

In Africa, recent studies have reported that HIV may exhibit a cardiac tropism. The purpose of this study was to determine if clinical features, sex, age at onset, biological or echocardiographic variables have any influence on survival of African HIV-infected patients and AIDS progression. One hundred and fifty seven consecutive HIV-seropositive patients without cardiac lesions and no other AIDS-defining illnesses underwent physical, electrocardiographic and Doppler echocardiographic examinations at the Heart of Africa Cardiovascular Centre, Lomo Medical, Kinshasa, Congo, between July 1987 and July 1994. Odds ratios were calculated to assess the influence of potential risk factors on cardiac lesions, opportunistic diseases, and death outcomes. Cardiac lesions had occurred in 87 patients (55%) during 7-year follow up. The onset of heart involvement was associated with a protection against opportunistic comorbidity. In multiple regression model, cardiac mass/volume ratio, body temperature, deceleration time, body mass index and socio-economic status were each independently associated with AIDS outcome. In a multivariate analysis the lowest socioeconomic status and the pericardial effusion were the independent predictors of death. The higher CD4 count and cardiac lesions outcome were connected with slower progression to AIDS. Dilated cardiomyopathy was associated with longer survival.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Biology; Blacks; Cardiovascular Effects; Congo; Cultural Background; Demographic Factors; Developing Countries; Diseases; Ethnic Groups; French Speaking Africa; Heart Diseases; Hiv Infections; Length Of Life; Middle Africa; Mortality; Physiology; Population; Population Characteristics; Population Dynamics; Research Report; Survivorship--determinants; Viral Diseases

Mesh:

Year:  1998        PMID: 9579818     DOI: 10.1016/s0167-5273(97)00321-5

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  22 in total

1.  QTc interval prolongation in patients with HIV and AIDS.

Authors:  Mahmoud U Sani; Basil N Okeahialam
Journal:  J Natl Med Assoc       Date:  2005-12       Impact factor: 1.798

2.  Determinants of HIV-related cardiac disease among adults in north central Nigeria.

Authors:  Godsent Isiguzo; Basil Okeahialam; Solomon Danbauchi; Augustin Odili; Michael Iroezindu
Journal:  Heart Asia       Date:  2013-07-09

Review 3.  HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future research.

Authors:  Gerald S Bloomfield; Prateeti Khazanie; Alison Morris; Cristina Rabadán-Diehl; Laura A Benjamin; David Murdoch; Virginia S Radcliff; Eric J Velazquez; Charles Hicks
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

Review 4.  Cardiovascular disease in Africa: epidemiological profile and challenges.

Authors:  Ashley K Keates; Ana O Mocumbi; Mpiko Ntsekhe; Karen Sliwa; Simon Stewart
Journal:  Nat Rev Cardiol       Date:  2017-02-23       Impact factor: 32.419

Review 5.  Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries.

Authors:  Gerald S Bloomfield; Fawaz Alenezi; Felix A Barasa; Rebecca Lumsden; Bongani M Mayosi; Eric J Velazquez
Journal:  JACC Heart Fail       Date:  2015-08       Impact factor: 12.035

Review 6.  Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa.

Authors:  Bongani M Mayosi
Journal:  Heart       Date:  2007-10       Impact factor: 5.994

Review 7.  Cardiac manifestations of HIV infection: an African perspective.

Authors:  Mpiko Ntsekhe; Bongani M Mayosi
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-12-23

8.  Mitochondrial DNA impairment in nucleoside reverse transcriptase inhibitor-associated cardiomyopathy.

Authors:  James J Kohler; Seyed H Hosseini; William Lewis
Journal:  Chem Res Toxicol       Date:  2008-04-05       Impact factor: 3.739

Review 9.  Etiology and pathophysiology of heart failure in people with HIV.

Authors:  Harry Choi; Amit K Dey; Gaurav Sharma; Rahul Bhoite; Greer Burkholder; Savitri Fedson; Hani Jneid
Journal:  Heart Fail Rev       Date:  2021-02-22       Impact factor: 4.214

Review 10.  Heart failure in sub-Saharan Africa.

Authors:  Gerald S Bloomfield; Felix A Barasa; Jacob A Doll; Eric J Velazquez
Journal:  Curr Cardiol Rev       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.